Med-Chemist : "Quintessential Medicinal Chemistry"
Thursday, October 6, 2022
Drug turns cancer gene into 'eat me' flag for immune system
›
Sotorasib The new therapy, described Sept. 12 in Cell Cancer , pulls a mutated version of the protein KRAS to the surface of cancer cells, ...
Wednesday, October 5, 2022
Smoking May Increase Odds of Meniere Disease in Men
›
For men, smoking is positively related and alcohol consumption is negatively related to the risk for Meniere disease (MD), according to a st...
Tuesday, October 4, 2022
Daily Multivitamin May Protect Against Cognitive Decline in Older Adults
›
In continuation of my update on Vitamin and their importance A daily multivitamin may provide cognitive benefits for older adults, accordi...
Monday, October 3, 2022
FDA Approves Zoryve (roflumilast) Cream for the Treatment of Plaque Psoriasis
›
Arcutis Biotherapeutics, Inc. an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...
Friday, September 30, 2022
FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults
›
dextromethorphan Bupropion In continuation of my updates on dextromethorphan and Bupropion , Axsome Therapeutics, Inc. , a...
Thursday, September 29, 2022
FDA Approves Konvomep (omeprazole and sodium bicarbonate for oral suspension) for Gastric Ulcer and Reduction of Risk of Gastrointestinal Bleeding in Critically Ill Patients
›
In continuation of my update on omeprazole Azurity Pharmaceuticals, Inc., a pharmaceutical company focused on developing innovative do...
Monday, September 26, 2022
FDA Approves Sotyktu (deucravacitinib) for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis
›
Bristol Myers Squibb (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) approval of Sotyktu ™ (deucravacitinib), a fi...
Friday, September 23, 2022
FDA Approves Terlivaz (terlipressin) for the Treatment of Hepatorenal Syndrome (HRS)
›
Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, announced the U.S. Food and Drug Administration (FDA) ap...
Thursday, September 22, 2022
FDA Approves Aponvie (aprepitant) for the Prevention of Postoperative Nausea and Vomiting (PONV)
›
In continuation of my update on aprepitant Heron Therapeutics, Inc., a commercial-stage biotechnology company focused on improving t...
Monday, September 12, 2022
Acadia Pharmaceuticals Announces Trofinetide New Drug Application for the Treatment of Rett Syndrome has been Accepted for Filing and Review by U.S. FDA
›
About Rett Syndrome Rett syndrome is a rare genetic neurodevelopmental disorder that occurs primarily in females following a near normal dev...
‹
›
Home
View web version